Literature DB >> 561128

Abnormal polyclonal B cell activation in NZB/NZW F1 mice.

P L Cohen, M Ziff.   

Abstract

Spleen cells from autoimmune (10-mont-old) NZB/NZW (B/W) mice failed to generate appreciable numbers of antibody-forming cells (AFC) in vitro to TNP-substituted sheep erythrocytes in response to the polyclonal B cell activators (PBA), LPS and PPD, despite normal DNA synthetic responses to these agents and normal AFC responses to TNP-Ficoll. The failure to respond to PBA in old B/W mice was not due to suppressor T cells since anti-brain-associated-theta-treated spleen cells still failed to generate AFC in response to PBA. The defect was age-related since cells from young B/W mice generated vigorous AFC responses to PBA. It is suggested that the failure of the spleen cells of old B/W mice to generate AFC is a result of in vitro polyclonal B cell activation in the course of autoantibody formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 561128

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  γδ T cells affect IL-4 production and B-cell tolerance.

Authors:  Yafei Huang; Ryan A Heiser; Thiago O Detanico; Andrew Getahun; Greg A Kirchenbaum; Tamara L Casper; M Kemal Aydintug; Simon R Carding; Koichi Ikuta; Hua Huang; John C Cambier; Lawrence J Wysocki; Rebecca L O'Brien; Willi K Born
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

3.  Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Authors:  Rei Watanabe; Nobuko Ishiura; Hiroko Nakashima; Yoshihiro Kuwano; Hitoshi Okochi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

4.  Effects of antigen and internal environment on anti-phosphorylcholine immune responses of autoimmune aged NZB/W F1 mice.

Authors:  R Seoane; J Faro; A Eiras; I Lareo; J Couceiro; B J Regueiro
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

5.  Functional absence of a B cell subpopulation in ageing New Zealand mice.

Authors:  P L Cohen
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

6.  Disordered immune homeostasis in chronic idiopathic thrombocytopenic purpura.

Authors:  R J Trent; R L Clancy; V Danis; A Basten
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

7.  Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo.

Authors:  I Zan-Bar; M Barzilay; M Moscovitch; S Slavin
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

8.  Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.

Authors:  H M Moutsopoulos; A S Fauci
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

9.  Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

Authors:  J F Delfraissy; P Segond; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.

Authors:  A N Theofilopoulos; D L Shawler; R A Eisenberg; F J Dixon
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.